GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kali Inc (OTCPK:KALY) » Definitions » Beneish M-Score

Kali (KALY) Beneish M-Score : 0.00 (As of May. 09, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Kali Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Kali's Beneish M-Score or its related term are showing as below:

During the past 7 years, the highest Beneish M-Score of Kali was 0.00. The lowest was 0.00. And the median was 0.00.


Kali Beneish M-Score Historical Data

The historical data trend for Kali's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kali Beneish M-Score Chart

Kali Annual Data
Trend Nov06 Nov07 Nov08 Dec09 Dec10 Dec11 Dec12
Beneish M-Score
Get a 7-Day Free Trial - - - 3.40 -2.00

Kali Quarterly Data
May08 Aug08 Nov08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,000,000.00 -2.70 -2.18 -2.00 -0.40

Competitive Comparison of Kali's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Kali's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kali's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kali's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Kali's Beneish M-Score falls into.



Kali Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Kali for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 2.2227+0.528 * 1.0398+0.404 * 0.6693+0.892 * 1.2812+0.115 * 1.0649
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.6882+4.679 * 0.18929-0.327 * 1.4016
=-0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar13) TTM:Last Year (Mar12) TTM:
Total Receivables was $50.9 Mil.
Revenue was 26.61 + 31.601 + 22.496 + 25.268 = $106.0 Mil.
Gross Profit was 11.538 + 12.679 + 10.126 + 11.465 = $45.8 Mil.
Total Current Assets was $84.1 Mil.
Total Assets was $90.5 Mil.
Property, Plant and Equipment(Net PPE) was $1.1 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.9 Mil.
Selling, General, & Admin. Expense(SGA) was $18.4 Mil.
Total Current Liabilities was $15.8 Mil.
Long-Term Debt & Capital Lease Obligation was $0.0 Mil.
Net Income was 5.661 + 7.466 + 3.052 + 4.865 = $21.0 Mil.
Non Operating Income was 0 + 0.01 + 0.096 + 0.249 = $0.4 Mil.
Cash Flow from Operations was 2.948 + 6.007 + -7.31 + 1.907 = $3.6 Mil.
Total Receivables was $17.9 Mil.
Revenue was 15.164 + 31.006 + 15.955 + 20.588 = $82.7 Mil.
Gross Profit was 7.777 + 13.632 + 6.51 + 9.256 = $37.2 Mil.
Total Current Assets was $52.9 Mil.
Total Assets was $60.2 Mil.
Property, Plant and Equipment(Net PPE) was $2.0 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.9 Mil.
Selling, General, & Admin. Expense(SGA) was $20.9 Mil.
Total Current Liabilities was $7.5 Mil.
Long-Term Debt & Capital Lease Obligation was $0.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(50.884 / 105.975) / (17.868 / 82.713)
=0.480151 / 0.216024
=2.2227

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(37.175 / 82.713) / (45.808 / 105.975)
=0.449446 / 0.432253
=1.0398

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (84.129 + 1.114) / 90.533) / (1 - (52.914 + 2.005) / 60.172)
=0.058432 / 0.0873
=0.6693

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=105.975 / 82.713
=1.2812

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.863 / (1.863 + 2.005)) / (0.92 / (0.92 + 1.114))
=0.481644 / 0.452311
=1.0649

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(18.435 / 105.975) / (20.908 / 82.713)
=0.173956 / 0.252778
=0.6882

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 15.78) / 90.533) / ((0 + 7.483) / 60.172)
=0.174301 / 0.12436
=1.4016

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(21.044 - 0.355 - 3.552) / 90.533
=0.18929

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Kali has a M-score of -0.40 signals that the company is likely to be a manipulator.


Kali (KALY) Business Description

Traded in Other Exchanges
N/A
Address
8300 Douglas Avenue, Suite 800, Dallas, TX, USA, 75225
Kali Inc is a United States based company involved in cannabis extraction business. It focuses on development of pharmaceuticals to treat various illnesses, diseases and chronic pain as a symptom of various diagnoses. The company also concentrates on the development of health and wellness therapies.
Executives
Tchaikovsky Bennet Price Jr officer: Chief Financial Officer 11601 WILSHIRE BOULEVARD, SUITE 2150, LOS ANGELES CA 90025
Ying Teresa Zhang director NO. 9 YANYU MIDDLE ROAD, QIANZHOU VILLAGE, HUISHAN DISTRICT, WUXI JIANGSU F4 214181
Bradley W Miller director, 10 percent owner, officer: CEO BLOCK C FLAT 410, LOTUS HILL GOLF APTS., LOTUS HILL TOWN, PANYU DISTRICT, GUANGZHOU F4 511440